Exane Asset Management’s Allergan plc AGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2020
Q1
Sell
-58,402
Closed -$11.2M 23
2019
Q4
$11.2M Buy
58,402
+10,000
+21% +$1.8M 13.71% 2
2019
Q3
$8.15M Buy
48,402
+28,402
+142% +$4.63M 6.25% 8
2019
Q2
$3.35M Buy
+20,000
New +$2.77M 1.49% 24
2019
Q1
Sell
-579
Closed -$77.4K 113
2018
Q4
$77.4K Buy
+579
New +$94.9K 0.05% 82
2016
Q4
Sell
-69,993
Closed -$16.1M 44
2016
Q3
$16.1M Sell
69,993
-15,822
-18% -$3.87M 5.05% 8
2016
Q2
$19.8M Buy
85,815
+39,892
+87% +$9.2M 7.69% 2
2016
Q1
$12.3M Buy
45,923
+18,797
+69% +$5.38M 6.41% 4
2015
Q4
$8.48M Buy
+27,126
New +$8.08M 5.14% 6

Other funds holding AGN

Exane Asset Management's AGN Position: Q1 2020 in Review

Exane Asset Management sold out of Allergan plc (AGN) in Q1 2020, closing a stake of 58,402 shares — an estimated $11.2M sold.

Exane Asset Management first reported a position in AGN in Q4 2015 and held it in 8 quarters. The position peaked at $19.8M in Q2 2016. 875 funds tracked by Wall St. Rank hold AGN as of Q1 2020.

  • Exane Asset Management reported no remaining Allergan plc position as of Q1 2020 after selling out during the quarter.
  • Exane Asset Management sold 58,402 Allergan plc shares in Q1 2020, an estimated $11.2M.
  • Exane Asset Management first reported a position in Allergan plc in Q4 2015 and held it in 8 quarters.
  • Exane Asset Management's Allergan plc position peaked at $19.8M in Q2 2016.
  • 875 funds tracked by Wall St. Rank held Allergan plc as of Q1 2020.

Based on Exane Asset Management's 13F filing for Q1 2020, filed 22 Apr 2020.